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Abstract
Many drugs have been designed to treat diseases of the central nervous system (CNS), especially neurodegenerative
diseases. However, the presence of tight junctions at the blood-brain barrier has often compromised the efficiency of
drug delivery to target sites in the brain. The principles of drug delivery systems across the blood-brain barrier are
dependent on substrate-specific (i.e. protein transport and transcytosis) and non-specific (i.e. transcellular and
paracellular) transport pathways, which are crucial factors in attempts to design efficient drug delivery strategies. This
review describes how the blood-brain barrier presents the main challenge in delivering drugs to treat brain diseases
and discusses the advantages and disadvantages of ongoing neurotherapeutic delivery strategies in overcoming this
limitation. In addition, we discuss the application of colloidal carrier systems, particularly nanoparticles, as potential
tools for therapy for the CNS diseases. © 2019 Bentham Science Publishers.
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